<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="EN">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id>
      <journal-id journal-id-type="publisher-id">CI</journal-id>
      <journal-id journal-id-type="publisher-id">Cancer Imaging</journal-id>
      <journal-title>Cancer Imaging</journal-title>
      <issn pub-type="ppub">1740-5025</issn>
      <issn pub-type="epub">1470-7330</issn>
      <publisher>
        <publisher-name>e-Med</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18390387</article-id>
      <article-id pub-id-type="pmc">2324367</article-id>
      <article-id pub-id-type="doi">10.1102/1470-7330.2008.0005</article-id>
      <article-id pub-id-type="publisher-id">ci080005</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Magnetic resonance imaging features of renal synovial sarcoma: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Zakhary</surname>
            <given-names>Mina M.</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">
            <sup>a</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Elsayes</surname>
            <given-names>Khaled M.</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">
            <sup>b</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Platt</surname>
            <given-names>Joel F.</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">
            <sup>b</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Francis</surname>
            <given-names>Isaac R.</given-names>
          </name>
          <xref ref-type="aff" rid="AFF1">
            <sup>b</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="AFF1"><sup>a</sup>School of Medicine, University of Michigan, Ann Arbor, MI, USA; <sup>b</sup>Department of Radiology, University of Michigan, Ann Arbor, MI 48105, USA</aff>
      <author-notes>
        <corresp>Corresponding address: Dr Khaled M. Elsayes, MD, Department of Radiology, University of Michigan, Ann Arbor, MI 48105, USA. Email: <email>kelsayes@med.umich.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>3</month>
        <year>2008</year>
      </pub-date>
      <volume>8</volume>
      <issue>1</issue>
      <fpage>45</fpage>
      <lpage>47</lpage>
      <history>
        <date date-type="accepted">
          <day>21</day>
          <month>1</month>
          <year>2008</year>
        </date>
      </history>
      <copyright-statement>&#xA9; 2008 International Cancer Imaging Society</copyright-statement>
      <copyright-year>2008</copyright-year>
      <abstract>
        <title>Abstract</title>
        <p>Primary renal synovial sarcoma (SS) was first described in 2000 by Argani, with only a few subsequent cases being reported in the English literature. Herein, we describe a case of a 52-year-old woman who presented with right flank pain. Magnetic resonance imaging revealed a 6-cm mass in the lower pole of the right kidney. T1 and T2 weighted imaging revealed a heterogeneous mass with triple sign. There was post-contrast enhancement. Imaging, histology and immunostaining together made the diagnosis of SS of the kidney.</p>
      </abstract>
      <kwd-group>
        <kwd>Synovial sarcoma</kwd>
        <kwd>kidney</kwd>
        <kwd>renal</kwd>
        <kwd>MRI</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Synovial sarcoma (SS) most commonly affects the para-articular regions of the extremities of young adults<xref ref-type="bibr" rid="B1"><sup>[1]</sup></xref>,<xref ref-type="bibr" rid="B2"><sup>[2]</sup></xref>. Occasionally, however, SS has been identified in less common locations, including the head and neck, heart, lungs and prostate<xref ref-type="bibr" rid="B3"><sup>[3]</sup></xref>. The first reported case of renal SS was described in 2000<xref ref-type="bibr" rid="B4"><sup>[4]</sup></xref>.</p>
      <p>Herein, we describe a case of primary renal SS, an exceedingly rare diagnosis, in a 52-year-old woman. The diagnosis was established by histology and immunostaining. To our knowledge, based on a review of the English literature, this marks the first case report describing the magnetic resonance (MR) features of synovial sarcoma of the kidney.</p>
    </sec>
    <sec>
      <title>Case report</title>
      <p>A 52-year-old female presenting with a history of right flank pain underwent computed tomography (CT) examination which revealed an amorphous partially cystic right lower pole renal mass with heterogeneous enhancement. Further workup with magnetic resonance imaging revealed a 6.0&#x2009;&#xD7;&#x2009;5.9&#x2009;&#xD7;&#x2009;6.1&#x2009;cm mass in the lower pole of the right kidney. Three-plane localizer, coronal single shot fast spin echo (SSFSE) T2, axial in and out of phase, axial fat suppressed T2 weighted, axial 5-min and 10-min delayed, and axial 3D liver acquisition with volume acceleration (LAVA) sequences were acquired. On T1 weighted imaging (<xref ref-type="fig" rid="F1">Fig. 1</xref>A), the mass was heterogeneous, with the posterior region having similar intensity to skeletal muscle and the anterior region with higher signal intensity. On chemical shift imaging, the tumor showed no areas of signal intensity loss. Axial T2 weighted imaging revealed marked heterogeneity with areas of high, intermediate, and low signal, known as the &#x2018;triple sign&#x2019;<xref ref-type="bibr" rid="B1"><sup>[1]</sup></xref> (<xref ref-type="fig" rid="F1">Fig. 1</xref>B). The mass contained multiple areas of high T2 signal emanating from the center of the mass, with surrounding intermediate and low T2 signal intensity regions (<xref ref-type="fig" rid="F1">Fig. 1</xref>E). These low T2 areas showed enhancement on post-contrast images (<xref ref-type="fig" rid="F1">Fig. 1</xref>C,D). The posterior aspect of the mass appeared solid. Our prospective diagnosis based on these MR imaging findings was renal cell carcinoma.
<fig id="F1" position="float"><label><italic>Figure 1</italic></label><caption><p><bold>Axial in-phase T1 weighted gradient recalled echo (GRE) image (A), showing a heterogeneous mass lesion involving the medial portion of the lower pole of the right kidney (arrow), with a posterior isointense area and an anterior area of higher signal intensity, relative to skeletal muscle. Axial fat suppressed T2 (B) and coronal SSFSE T2 images (E) show marked heterogeneity and the &#x2018;triple sign;: areas of low, intermediate and high signal intensity (arrows). Axial post-contrast GRE image (C and D) shows enhancement of the T2 hypo-intense areas (arrow).</bold></p></caption><graphic xlink:href="ci08000501"/></fig></p>
      <p>The patient underwent right nephrectomy with a pathological diagnosis of high-grade, poorly differentiated spindle-cell synovial sarcoma. Immunohistochemical staining showed focal positivity for cytokeratin CAM 5.2 and negativity for S100, CK7, and epithelial membrane antigen (EMA). The diagnosis of primary synovial sarcoma of the kidney was made.</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>The most common sarcoma of the kidney is leiomyosarcoma, accounting for 40&#x2013;60% of reported cases. Primary SS of the kidney is a rare tumor<xref ref-type="bibr" rid="B4"><sup>[4]</sup></xref>. The first set of 15 cases reported was in 2000, by Argani<xref ref-type="bibr" rid="B4"><sup>[4]</sup></xref>, with few other cases reported in the English literature. There have been no reports to date describing the MR imaging findings of primary SS of the kidney. The mean age of presentation is 37.5 years. There is a slight male predominance, with a male-to-female ratio of 1.2. Furthermore, there seems to be a predilection for the right kidney, with a right-to-left ratio of 2.2.</p>
      <p>The typical presentation of SS of the kidney is non-specific, and resembles that of other primary tumors of the kidney<xref ref-type="bibr" rid="B4"><sup>[4]</sup></xref>. Patients may complain of localized flank or back pain, hematuria, or a palpable abdominal mass. Imaging is often required for further evaluation.</p>
      <p>For synovial sarcomas in general, the imaging modality of choice is magnetic resonance imaging (MRI), given its high sensitivity for soft tissue abnormalities. Although diagnostic for some soft tissue tumors, MR signal intensity characteristics are usually non-specific for SS<xref ref-type="bibr" rid="B1"><sup>[1]</sup></xref>.</p>
      <p>Most synovial sarcomas tend to be large masses, averaging 8&#x2009;cm in size. The tumors have low invasion potential. The most common MR finding is an oval, well-defined nodular mass. On T1 weighted imaging, small lesions are typically homogenous, with a signal intensity similar to that of skeletal muscle<xref ref-type="bibr" rid="B5"><sup>[5]</sup></xref>, while lesions larger than 5&#x2009;cm often exhibit intermediate intensity signal and are heterogeneous secondary to hemorrhagic and necrotic areas<xref ref-type="bibr" rid="B1"><sup>[1]</sup></xref>. On T2 weighted imaging<xref ref-type="bibr" rid="B6"><sup>[6]</sup></xref>,<xref ref-type="bibr" rid="B7"><sup>[7]</sup></xref>, lesions are hyperintense, usually with intratumoral hemorrhage (73%) and cystic components (77%); 35&#x2013;57% exhibit the triple sign, showing areas that are hyper-, iso-, and hypo-intense relative to skeletal muscle, representing hemorrhage/necrosis, septa/cellular elements, and calcified/fibrotic areas; however, this is also seen in other soft tissue tumors, namely malignant fibrous histiocytoma<xref ref-type="bibr" rid="B1"><sup>[1]</sup></xref>,<xref ref-type="bibr" rid="B5"><sup>[5]</sup></xref>. MR imaging after intravenous contrast injection shows heterogeneous enhancement<xref ref-type="bibr" rid="B8"><sup>[8]</sup></xref>.</p>
      <p>Histologically, SS consists of round spindle cells with minimal cytoplasm and active mitotic figures. Cysts lined with epithelial cells containing eosinophilic cytoplasm are usually visible<xref ref-type="bibr" rid="B3"><sup>[3]</sup></xref>. These tumors are further divided into two subtypes, monophasic and biphasic, depending on the absence or presence of a well-develop glandular epithelium<xref ref-type="bibr" rid="B4"><sup>[4]</sup></xref>. The monophasic form is more common, and has a poorer prognosis. No radiographic distinction has been made between monophasic and biphasic tumors<xref ref-type="bibr" rid="B1"><sup>[1]</sup></xref>.</p>
      <p>Although, synovial sarcoma in any location is regarded as slow growing, it should be considered a systemic disease. Indeed, 25% have pulmonary metastases at the time of diagnosis. Despite wide surgical resection, local recurrence and metastatic disease are common, seen in more than 40%<xref ref-type="bibr" rid="B1"><sup>[1]</sup></xref>. There is no established treatment protocol for SS. However, SS, more than other sarcomas, are more often treated with neoadjuvant chemotherapy followed by surgical treatment<xref ref-type="bibr" rid="B9"><sup>[9]</sup></xref>. These tumors demonstrate moderate chemo sensitivity, with 50% response rates to ifosfamide-based or doxorubicin-based regimens<xref ref-type="bibr" rid="B4"><sup>[4]</sup></xref>. Studies of extremity SS have shown that ifosfamide-based chemotherapy reduces tumor volume by greater than 50% and improves disease-specific survival<xref ref-type="bibr" rid="B10"><sup>[10]</sup></xref>. In contrast, renal cell carcinoma is generally considered chemoresistant, although newer drug therapies such as sorafenib and sunitinib have led to some optimism<xref ref-type="bibr" rid="B11"><sup>[11]</sup></xref>,<xref ref-type="bibr" rid="B12"><sup>[12]</sup></xref>.</p>
      <p>Prognosis of primary renal SS is unknown given the rarity of the diagnosis. Multiple studies of SS of the extremity have shown a strong association between tumor size<xref ref-type="bibr" rid="B13"><sup>[13]</sup></xref>, volume<xref ref-type="bibr" rid="B10"><sup>[10]</sup></xref>, and histological grade<xref ref-type="bibr" rid="B14"><sup>[14]</sup></xref> to disease recurrence and patient mortality. Radiographic findings that had prognostic significance in SS were investigated<xref ref-type="bibr" rid="B15"><sup>[15]</sup></xref>. High grade SS is favored in tumors that exhibit cystic components, hemorrhage, and fluid levels, as well as the triple sign. Absence of calcification was also weakly associated with high-grade tumors.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>[1]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murphey</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Jennings</surname>
              <given-names>BT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>From the archives of the AFIP: imaging of synovial sarcoma with radiologic-pathologic correlation</article-title>
          <source>Radiographics</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>1543</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="pmid">16973781</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <label>[2]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Yen</surname>
              <given-names>CC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary renal synovial sarcoma with inferior vena cava and right atrium invasion</article-title>
          <source>International J Urol</source>
          <year>2003</year>
          <volume>10</volume>
          <fpage>657</fpage>
          <lpage>60</lpage>
        </citation>
      </ref>
      <ref id="B3">
        <label>[3]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shannon</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Murch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Primary renal synovial sarcoma confirmed by cytogenetic analysis: a lesion distinct from sarcomatoid renal cell carcinoma</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2005</year>
          <volume>129</volume>
          <fpage>238</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">15679430</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <label>[4]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Argani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Faria</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>JI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary renal synovial sarcoma</article-title>
          <source>Am J Surg Pathol</source>
          <year>2000</year>
          <volume>24</volume>
          <fpage>1087</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="pmid">10935649</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <label>[5]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>QY</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>RX</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Correlation of MR imaging features and histopathology of synovial sarcoma</article-title>
          <source>Ai Zheng</source>
          <year>2005</year>
          <volume>24</volume>
          <fpage>87</fpage>
          <lpage>90</lpage>
          <comment>(Abstract)</comment>
          <pub-id pub-id-type="pmid">15642208</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <label>[6]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Valenzuela</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Seo</surname>
              <given-names>JG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A revisit of MRI analysis for synovial sarcoma</article-title>
          <source>J Clin Imaging</source>
          <year>2000</year>
          <volume>24</volume>
          <fpage>231</fpage>
          <lpage>5</lpage>
        </citation>
      </ref>
      <ref id="B7">
        <label>[7]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakanishi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Araki</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sawai</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cystic synovial sarcomas: imaging features with clinical and histopathologic correlation</article-title>
          <source>Skeletal Radiol</source>
          <year>2003</year>
          <volume>32</volume>
          <fpage>701</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">14564484</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <label>[8]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monzen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hirai</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nishisaka</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MR imaging of synovial sarcoma arising from the floor of the mouth: a case report</article-title>
          <source>Radiat Med</source>
          <year>2001</year>
          <volume>19</volume>
          <fpage>47</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">11305619</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <label>[9]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grobmyer</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Maki</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Demetri</surname>
              <given-names>GD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma</article-title>
          <source>Ann Oncol</source>
          <year>2004</year>
          <volume>15</volume>
          <fpage>1667</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="pmid">15520069</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <label>[10]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eilber</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Eilber</surname>
              <given-names>FR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma</article-title>
          <source>Ann Surg</source>
          <year>2007</year>
          <volume>246</volume>
          <fpage>105</fpage>
          <lpage>113</lpage>
          <pub-id pub-id-type="pmid">17592298</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <label>[11]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Motzer</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Hutson</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Tomczak</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sunitinib versus interferon alfa in metastatic renal-cell carcinoma</article-title>
          <source>N Engl J Med</source>
          <year>2007</year>
          <volume>356</volume>
          <fpage>115</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">17215529</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <label>[12]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Escudier</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Eisen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Stadler</surname>
              <given-names>WM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>TARGET Study Group. Sorafenib in advanced clear-cell renal-cell carcinoma</article-title>
          <source>N Engl J Med</source>
          <year>2007</year>
          <volume>356</volume>
          <fpage>125</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">17215530</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <label>[13]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lewis</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Antonescu</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>DH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity</article-title>
          <source>J Clin Oncol</source>
          <year>2000</year>
          <volume>18</volume>
          <fpage>2087</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="pmid">10811674</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <label>[14]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guillou</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Benhattar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bonichon</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis</article-title>
          <source>J Clin Oncol</source>
          <year>2004</year>
          <volume>22</volume>
          <fpage>4040</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">15364967</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <label>[15]</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tateishi</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Beppu</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Synovial sarcoma of the soft tissues: prognostic significance of imaging features</article-title>
          <source>J Comput Assist Tomogr</source>
          <year>2004</year>
          <volume>28</volume>
          <fpage>140</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">14716248</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
